Cargando…
Case Report: Anti-NF186+ CIDP After Receiving the Inactivated Vaccine for Coronavirus Disease (COVID-19)
Corona Virus Disease 2019 (COVID-19), the novel coronavirus disease, is now a global pandemic. Vaccination can significantly reduce the mortality rate caused by the severe acute respiratory syndrome of coronavirus 2 (SARS-CoV-2). There are currently several effective vaccines that have been introduc...
Autores principales: | Wen, Shirui, Huang, Kailing, Zhu, Haoyue, Li, Peihong, Zhou, Luo, Feng, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8964034/ https://www.ncbi.nlm.nih.gov/pubmed/35359644 http://dx.doi.org/10.3389/fneur.2022.838222 |
Ejemplares similares
-
Treatment Approaches for Atypical CIDP
por: Menon, Deepak, et al.
Publicado: (2021) -
Editorial: Update on the Diagnosis and Management of CIDP Variants
por: Chroni, Elisabeth, et al.
Publicado: (2021) -
Pediatric CIDP: Diagnosis and Management. A Single-Center Experience
por: Łukawska, Małgorzata, et al.
Publicado: (2021) -
Neurofascin (NF)155- and NF186-Specific T Cell Response in a Patient Developing a Central Pontocerebellar Demyelination after 10 Years of CIDP
por: Klehmet, Juliane, et al.
Publicado: (2017) -
Validation of the Chinese Version of the Stigma Scale of Epilepsy
por: Wu, Yuanxia, et al.
Publicado: (2022)